{"result": "{\n    \"title\": \"Breast Cancer Community\",\n    \"summary\": \"The Breast Cancer Community revolves around the entities related to breast cancer, including Breast Cancer, IBC, Systemic Treatment, Targeted Therapy, and Clinical Trials. The community is characterized by the relationships between these entities, with Breast Cancer being the central entity.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The impact severity rating is high due to the potential for adverse events and the importance of effective treatment options.\",\n    \"findings\": [\n        {\n            \"summary\": \"Breast Cancer as the central entity\",\n            \"explanation\": \"Breast Cancer is the central entity in this community, with IBC being a subtype of Breast Cancer. The relationships between Breast Cancer and other entities, such as Systemic Treatment and Targeted Therapy, highlight the importance of effective treatment options. [Data: Entities (9, 11, 6); Relationships (30, 40, 61)]\"\n        },\n        {\n            \"summary\": \"Systemic Treatment as a key approach\",\n            \"explanation\": \"Systemic Treatment is a key approach in the treatment of Breast Cancer, with various options including Chemotherapy, Targeted Therapy, and Immunotherapy. The relationships between Systemic Treatment and other entities, such as IBC and Clinical Trials, highlight its importance in the community. [Data: Entities (8, 12, 14); Relationships (40, 61, 137)]\"\n        },\n        {\n            \"summary\": \"Targeted Therapy as a promising option\",\n            \"explanation\": \"Targeted Therapy is a promising option in the treatment of Breast Cancer, targeting specific molecules involved in cancer growth. The relationships between Targeted Therapy and other entities, such as IBC and Clinical Trials, highlight its potential in the community. [Data: Entities (81, 2); Relationships (79, 61, 137)]\"\n        },\n        {\n            \"summary\": \"Clinical Trials as a key aspect\",\n            \"explanation\": \"Clinical Trials are a key aspect of the Breast Cancer Community, evaluating the safety and efficacy of new treatments. The relationships between Clinical Trials and other entities, such as Systemic Treatment and Targeted Therapy, highlight their importance in the community. [Data: Entities (77, 12, 14); Relationships (28, 29, 137)]\"\n        },\n        {\n            \"summary\": \"IBC as a specific type of Breast Cancer\",\n            \"explanation\": \"IBC is a specific type of Breast Cancer, characterized by rapid onset and aggressive progression. The relationships between IBC and other entities, such as Systemic Treatment and Targeted Therapy, highlight its importance in the community. [Data: Entities (6, 11, 8); Relationships (18, 28, 61)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n9,\"\"\"BREAST CANCER\"\"\",\"Here is a comprehensive summary of the data provided:\n\nBreast Cancer is a type of cancer that affects the breast tissue, with a risk of recurrence and potential survival benefits from extended adjuvant endocrine therapy. It is a disease that is being studied in various research papers and is the focus of multiple studies and research papers. Breast Cancer is a subtype of Inflammatory Breast Cancer and is treated with various systemic treatments, including Pazopanib and Lapatinib. The disease has improved treatment outcomes over the past two decades and is being researched and treated using various technologies and treatments.\n\nBreast Cancer is a type of cancer that affects women and is treated with various therapies, including high-dose chemotherapy with autologous hematopoietic stem-cell support. The disease is discussed in the text, including Inflammatory Breast Cancer (IBC) and non-IBC, and is being treated in the NeoSphere trial with T-DM1 and other therapies. Breast Cancer is a medical condition that was studied in several papers and is the subject of multiple studies.\n\nOverall, Breast Cancer is a type of cancer that requires treatment and is being extensively researched and treated using various therapies and technologies.\",9\r\n11,\"\"\"SYSTEMIC TREATMENT\"\"\",\"Here is a comprehensive summary of the data:\n\nSYSTEMIC TREATMENT refers to the use of medications to treat cancer, specifically breast cancer. It involves the administration of chemotherapy and targeted therapies to combat the disease. This type of treatment is a common approach for treating Inflammatory Breast Cancer (IBC), as well as other types of breast cancer.\n\nNote: I have resolved any potential contradictions by combining the information from each description to provide a clear and concise summary.\",8\r\n79,\"\"\"CRISTOFANILLI ET AL.\"\"\",\"Here is a comprehensive summary of the data:\n\nCristofanilli et al. are researchers who conducted a study on the effectiveness of paclitaxel in breast cancer treatment.\n\nThis summary provides a brief overview of the entity, Cristofanilli et al., and their research focus on the effectiveness of paclitaxel in breast cancer treatment.\",2\r\n81,\"\"\"TARGETED THERAPY\"\"\",\"Here is a comprehensive summary of the data:\n\nTargeted Therapy is a treatment option for breast cancer, including inflammatory breast cancer (IBC). It is a type of systemic treatment that targets specific molecules involved in cancer growth, making it a unique approach to cancer treatment. As a study topic, Targeted Therapy has been evaluated in clinical trials for the treatment of breast cancer, providing valuable insights into its effectiveness and potential benefits. Overall, Targeted Therapy is a promising treatment option for breast cancer patients, offering a targeted approach to combat the disease.\",2\r\n6,\"\"\"INFLAMMATORY BREAST CANCER\"\"\",\"Here is a comprehensive summary of the data:\n\nInflammatory Breast Cancer is a rare and aggressive type of breast cancer characterized by rapid onset and aggressive progression. It is a specific type of breast cancer that is studied in various research papers, articles, and texts, and is the subject of various studies and consensus statements. This type of breast cancer is characterized by rapid growth and spread of cancer cells, and is often treated with high-dose chemotherapy with autologous hematopoietic stem-cell support.\",5\r\n77,\"\"\"CLINICAL TRIALS\"\"\",\"Here is a comprehensive summary of the data:\n\nClinical trials are studies that evaluate the effectiveness, safety, and efficacy of various treatments for breast cancer, including new systemic regimens in patients with Inflammatory Breast Cancer (IBC). These studies investigate the potential role of new treatments in patients with breast cancer, with a focus on evaluating their ability to effectively treat the disease while ensuring their safety for patients.\",4\r\n235,\"\"\"COMBINATION THERAPY\"\"\",\"Here is a comprehensive summary of the data:\n\nCombination therapy refers to a treatment approach that combines multiple medications or treatments to address a disease or condition. Specifically, it involves the use of multiple treatments together to treat a specific disease or condition, such as breast cancer. This approach is designed to provide a more effective and comprehensive treatment plan, often resulting in better patient outcomes.\",6\r\n16,\"\"\"MOLECULAR SUBTYPES\"\"\",\"Here is a comprehensive summary of the data:\n\nMolecular Subtypes refer to the different biological characteristics of Invasive Breast Cancer (IBC) that can impact treatment outcomes, as well as the different types of breast cancer based on their molecular characteristics.\",2\r\n15,\"\"\"ADVERSE EVENTS\"\"\",\"Here is a comprehensive summary of the data:\n\nADVERSE EVENTS refer to the negative side effects that can occur during treatment for breast cancer, specifically for Inflammatory Breast Cancer (IBC). These adverse events are serious side effects that can occur as a result of treatment for breast cancer, including IBC.\",1\r\n12,\"\"\"PATHOLOGIC COMPLETE RESPONSE\"\"\",\"\"\"Pathologic Complete Response refers to the absence of cancer cells in the breast tissue after treatment.\"\"\",1\r\n14,\"\"\"PREDICTIVE MARKERS\"\"\",\"\"\"Predictive Markers are biological indicators that can predict the effectiveness of treatment for IBC.\"\"\",1\r\n13,\"\"\"SURVIVAL OUTCOMES\"\"\",\"Here is a comprehensive summary of the data:\n\nSurvival Outcomes refer to the length of time a patient with Inflammatory Breast Cancer (IBC) survives after treatment. The use of systemic treatments for breast cancer has led to improved survival outcomes for patients with IBC.\",1\r\n248,\"\"\"MONOTHERAPY\"\"\",\"\"\"Monotherapy refers to the use of a single treatment to treat breast cancer.\"\"\",2\r\n237,\"\"\"GRADE 3\u20134 ADVERSE EVENTS\"\"\",\"\"\"Grade 3\u20134 adverse events refer to severe side effects of a medication.\"\"\",1\r\n242,\"\"\"PROGRESSION-FREE SURVIVAL\"\"\",\"\"\"Progression-free survival refers to the length of time during which a disease does not worsen.\"\"\",1\r\n185,\"\"\"RESPONSE RATE\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"RESPONSE RATE\"\" refers to the percentage of participants or patients who respond to a treatment. It is a concept or marker that is associated with the effectiveness of treatment. In other words, response rate measures the proportion of individuals who exhibit a positive outcome or improvement in response to a particular treatment or intervention.\",1\r\n633,\"\"\"HER-2 POSITIVITY\"\"\",\"\"\"HER-2 positivity is a characteristic of breast cancer cells that overexpress the HER-2 protein.\"\"\",1\r\n7,\"\"\"SYSTEMIC THERAPY\"\"\",\"\"\"Systemic Therapy refers to the treatment of Inflammatory Breast Cancer.\"\"\",1\r\n8,\"\"\"TRIMODALITY TREATMENT\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"Trimodality Treatment\"\" is a treatment approach for Inflammatory Breast Cancer (IBC) that involves a composite of systemic treatment, surgery, and radiation. This treatment approach is specifically designed to address the unique characteristics and challenges of IBC, a rare and aggressive form of breast cancer.\n\nNote: I resolved the contradiction by assuming that the entity \"\"Trimodality Treatment\"\" is a treatment approach for Inflammatory Breast Cancer (IBC), as both descriptions mention IBC.\",1\r\n21,\"\"\"UNITED STATES\"\"\",\"Here is a comprehensive summary of the data:\n\nThe United States is a country where a study on breast cancer was conducted, and the incidence of Inflammatory Breast Cancer (IBC) is reported.\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n30,\"\"\"BREAST CANCER\"\"\",\"\"\"IBC\"\"\",\"\"\"IBC is a subtype of Breast Cancer that requires specific treatment.\"\"\",63\r\n40,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"IBC\"\"\",\"\"\"IBC is treated with systemic treatment, including chemotherapy and targeted therapy.\"\"\",62\r\n61,\"\"\"IBC\"\"\",\"\"\"CRISTOFANILLI ET AL.\"\"\",\"\"\"Cristofanilli et al. conducted a study on IBC patients.\"\"\",56\r\n79,\"\"\"IBC\"\"\",\"\"\"TARGETED THERAPY\"\"\",\"\"\"Targeted Therapy is a treatment option for IBC.\"\"\",56\r\n25,\"\"\"BREAST CANCER\"\"\",\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"Systemic Treatment is used to treat Breast Cancer, with various options including Chemotherapy, Targeted Therapy, and Immunotherapy.\"\"\",17\r\n18,\"\"\"INFLAMMATORY BREAST CANCER\"\"\",\"\"\"BREAST CANCER\"\"\",\"Here is a comprehensive summary of the data:\n\nInflammatory Breast Cancer (IBC) and Breast Cancer are two types of breast cancer that have been extensively studied in various research papers. IBC is a subtype of Breast Cancer, which means that it is a specific type of breast cancer that falls under the broader category of Breast Cancer.\",14\r\n28,\"\"\"BREAST CANCER\"\"\",\"\"\"NEOSPHERE TRIAL\"\"\",\"\"\"The NeoSphere trial tested the combination of pertuzumab with trastuzumab in breast cancer patients.\"\"\",13\r\n29,\"\"\"BREAST CANCER\"\"\",\"\"\"CLINICAL TRIALS\"\"\",\"\"\"Clinical trials are studies that evaluate the safety and efficacy of new treatments for breast cancer.\"\"\",13\r\n272,\"\"\"PAZOPANIB\"\"\",\"\"\"COMBINATION THERAPY\"\"\",\"\"\"Pazopanib is used in combination therapy to treat the disease.\"\"\",13\r\n27,\"\"\"BREAST CANCER\"\"\",\"\"\"IMMUNOTHERAPY\"\"\",\"\"\"Immunotherapy is a potential future direction for systemic therapy in Breast Cancer treatment, leveraging the body's immune system to fight cancer.\"\"\",12\r\n41,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"CLINICAL TRIALS\"\"\",\"\"\"Systemic treatment is investigated in clinical trials to determine its efficacy and toxicity in patients with IBC.\"\"\",12\r\n23,\"\"\"BREAST CANCER\"\"\",\"\"\"MOLECULAR SUBTYPES\"\"\",\"\"\"Breast cancer is classified into different molecular subtypes, which affect the choice of systemic treatment.\"\"\",11\r\n24,\"\"\"BREAST CANCER\"\"\",\"\"\"CRISTOFANILLI ET AL.\"\"\",\"\"\"Cristofanilli et al. conducted a study on the effectiveness of paclitaxel in breast cancer treatment, highlighting its potential as an active agent against breast cancer.\"\"\",11\r\n26,\"\"\"BREAST CANCER\"\"\",\"\"\"TARGETED THERAPY\"\"\",\"\"\"Targeted Therapy is used to treat Breast Cancer, targeting specific molecules involved in cancer growth.\"\"\",11\r\n137,\"\"\"CLINICAL TRIALS\"\"\",\"\"\"COMBINATION THERAPY\"\"\",\"\"\"Combination therapy is evaluated in clinical trials to determine its safety and efficacy in treating breast cancer.\"\"\",10\r\n39,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"MOLECULAR SUBTYPES\"\"\",\"\"\"Systemic Treatment is stratified by Molecular Subtypes in patients with IBC.\"\"\",10\r\n38,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"ADVERSE EVENTS\"\"\",\"\"\"Systemic Treatment can cause Adverse Events in patients with IBC.\"\"\",9\r\n35,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"PATHOLOGIC COMPLETE RESPONSE\"\"\",\"\"\"Systemic Treatment aims to achieve Pathologic Complete Response in patients with IBC.\"\"\",9\r\n37,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"PREDICTIVE MARKERS\"\"\",\"\"\"Predictive Markers can predict the effectiveness of Systemic Treatment for IBC.\"\"\",9\r\n36,\"\"\"SYSTEMIC TREATMENT\"\"\",\"\"\"SURVIVAL OUTCOMES\"\"\",\"\"\"Systemic Treatment affects Survival Outcomes in patients with IBC.\"\"\",9\r\n280,\"\"\"COMBINATION THERAPY\"\"\",\"\"\"MONOTHERAPY\"\"\",\"\"\"Combination therapy and monotherapy are two approaches to treating breast cancer, with combination therapy showing a numerically highest response rate.\"\"\",8\r\n278,\"\"\"COMBINATION THERAPY\"\"\",\"\"\"GRADE 3\u20134 ADVERSE EVENTS\"\"\",\"\"\"Grade 3\u20134 adverse events are more common in combination therapy than in lapatinib monotherapy.\"\"\",7\r\n279,\"\"\"COMBINATION THERAPY\"\"\",\"\"\"PROGRESSION-FREE SURVIVAL\"\"\",\"\"\"The progression-free survival is the same in the combination therapy and lapatinib monotherapy arms.\"\"\",7\r\n249,\"\"\"RESPONSE RATE\"\"\",\"\"\"COMBINATION THERAPY\"\"\",\"\"\"The response rate is highest in the combination therapy arm.\"\"\",7\r\n138,\"\"\"CLINICAL TRIALS\"\"\",\"\"\"MONOTHERAPY\"\"\",\"\"\"Monotherapy is evaluated in clinical trials to determine its safety and efficacy in treating breast cancer.\"\"\",6\r\n22,\"\"\"INFLAMMATORY BREAST CANCER\"\"\",\"\"\"HER-2 POSITIVITY\"\"\",\"\"\"inflammatory breast cancer is characterized by HER-2 positivity.\"\"\",6\r\n19,\"\"\"INFLAMMATORY BREAST CANCER\"\"\",\"\"\"SYSTEMIC THERAPY\"\"\",\"\"\"Systemic Therapy is used to treat Inflammatory Breast Cancer.\"\"\",6\r\n20,\"\"\"INFLAMMATORY BREAST CANCER\"\"\",\"\"\"TRIMODALITY TREATMENT\"\"\",\"\"\"Trimodality Treatment is used to treat Inflammatory Breast Cancer.\"\"\",6\r\n21,\"\"\"INFLAMMATORY BREAST CANCER\"\"\",\"\"\"UNITED STATES\"\"\",\"\"\"The incidence of Inflammatory Breast Cancer is reported in the United States.\"\"\",6\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": null}}